CN Patent

CN101193884A — 微管蛋白抑制剂和其制备方法

Assigned to Wyeth LLC · Expires 2008-06-04 · 18y expired

What this patent protects

本发明提供6－氯－5－{2，6－二氟－4－[3－(甲基氨基)丙氧基]苯基}－2－吡嗪－2－基－N－[(1S)－2，2，2－三氟－1－甲基乙基]嘧啶－4－胺半富马酸盐，其是用于治疗癌症的微管蛋白抑制剂；和制备所述半富马酸盐的方法。

USPTO Abstract

本发明提供6－氯－5－{2，6－二氟－4－[3－(甲基氨基)丙氧基]苯基}－2－吡嗪－2－基－N－[(1S)－2，2，2－三氟－1－甲基乙基]嘧啶－4－胺半富马酸盐，其是用于治疗癌症的微管蛋白抑制剂；和制备所述半富马酸盐的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN101193884A
Jurisdiction: CN
Classification: —
Expires: 2008-06-04
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.